- Are you interested in buying Hikma Pharma shares for exposure to the health sector?
- Learn how to buy and trade your shares.
- Get the info you need to keep track of your investment.
Hikma Pharmaceuticals (LSE: HIK) is a multinational pharmaceutical company based in London. Across thirty-two production sites, they produce generic, speciality, and branded pharmaceutical products.
Their primary markets are North America, Europe, the Middle East, and North Africa. Some of their best-selling products include Actos, Omnicef, Suprax, and Blopress.
Ready to invest in Hikma Pharma shares? Scroll down for a step-by-step guide.
Coming up next
80.2% of retail CFD accounts lose money
- Trade and invest in top financial instruments, including a wide selection of stocks.
- eToro is regulated by CySec, FCA and ASIC
- Your funds are protected by industry-leading security protocols.
- With fractional shares, you can start investing from only £2.
- Choose from thousands of stocks from the London Stock Exchange, NYSE and NASDAQ.
- Access to a wide range of ETFs and Investment trusts.
- Open an account and get £500 in trading commissions to use within 3 months.
- Access 26 global markets and trade 20,000+ financial instruments worldwide.
- Low fees and spreads, 0 commission and no markup on FTSE100, US and EU Shares CFDs, and no additional charges on stock prices, market spread only.
- Trade anywhere and hold GBP, EUR, USD and 20+ currencies in a single account.
- Offers easy-to-use trading platforms.
- Invest across 20 international exchanges in shares, funds, bonds and investment trusts.
- Dealing charges depend on how many trades you make each month.
Compare UK trading platforms with Finty. Research fees, commissions, tradable assets, markets, etc.
Step 1: Open an account
The London Stock Exchange is where Hikma Pharma is listed. Whatever broker you choose must be able to access this stock market in order to acquire their shares.
Before choosing a broker, think about their brokerage, what their foreign exchange fee is when buying on international markets, the markets and tradable assets they have access to, whether they support fractional share investments, and the overall usability of their trading platform.
Step 2: Transfer money
You’ll need to have cleared funds available in your account before placing a trade. The standard funding method is via a bank transfer or debit card, but some brokers will accept credit card payments or even PayPal. Funding options vary widely between brokers.
Step 3: Decide how much to invest
Investing in a single company’s shares can be volatile, so check your risk tolerance and only invest an amount that you can afford to lose.
Step 4: Decide between shares or an ETF
ETFs (Exchange Traded Funds) are a type of fund that tracks the performance of a group of companies in the same, or related, industries. While they are considered less risky than investing in individual shares, bear in mind that they are not entirely without risk.
ETFs that have shares in Hikma Pharma include iShares Core MSCI EAFE ETF (IEFA), Schwab International Equity ETF (SCHF), and Hartford Multifactor Developed Markets (ex-US) ETF (RODM).
Step 5: Set up your order
A market order, which can be configured up quickly and very easily, means you can buy Hikma Pharma shares at the next available price. Most brokers allow you to set up an order to automatically buy or sell shares once your preferred price objective is met. You may also be able to set up an order to automatically buy or sell shares on a recurring basis over time.
Step 6: Execute the order
Once you are satisfied with your order, submit it to buy your shares.
Keeping an eye on the share price is important, but so is tracking what is being said about Hikma in the news. Keep an eye on what their competitors are up to since they can have a big impact on Hikma’s share price. This also includes news stories that relate to the products that they sell or are developing.
Hikma’s main competitors are Teva (NYSE: TEVA), Novartis (SWX: NOVN), Lupin Pharmaceuticals (NSE: LUPIN), and Boehringer Ingelheim (BHGR).
Disclaimer: We put our customer’s needs first. The views expressed in this article are those of the writer’s alone and do not constitute financial advice. Advertisers cannot influence editorial content. However, Finty and/or the writer may have a financial interest in the companies mentioned. Finty is committed to providing factual, honest, and accurate information that is compliant with governing laws and regulations. Do your own due diligence and seek professional advice before deciding to invest in one of the products mentioned. For more information, see Finty’s editorial guidelines and terms and conditions.